Latest Healthcare Research Reports

Tag: Price

  • What Is The Predicted Revenue Outlook For The Global Catastrophic Antiphospholipid Syndrome Market To Surpass $6.17 Billion?

    What Is The Predicted Revenue Outlook For The Global Catastrophic Antiphospholipid Syndrome Market To Surpass $6.17 Billion?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Are The Market Size Estimates For The Catastrophic Antiphospholipid Syndrome Market?

    The market size for catastrophic antiphospholipid syndrome has seen rapid expansion in recent times. This market is predicted to expand from $3.76 billion in 2024 to reach $4.16 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.7%. The development during the historical period can be credited to the increased use of plasmapheresis and intravenous immunoglobulin (IVIG), the soaring accessibility of biologics and monoclonal antibodies, expanded patient support measures and advocacy for rare diseases, proliferating clinical trials for targeted treatments, and a rise in healthcare expenditure.

    The market size for catastrophic antiphospholipid syndrome is projected to experience significant expansion in the coming years, ballooning to a worth of $6.17 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.4%. This growth during the forecasted period can be linked to an increased occurrence of autoimmune diseases, heightened understanding among medical professionals, the expanding use of immunosuppressive treatments, a surge in thrombosis-related issues, and a growing demand for more advanced diagnostic equipment. Key trends to watch for in the forecast period are strides in autoantibody detection tech, the production of point-of-care diagnostic devices, the use of artificial intelligence in aiding clinical decisions, tech advancements in immunoassay platforms, and the creation of targeted biological drugs and monoclonal antibodies.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25718&type=smp

    Which Industry Forces Are Driving The Catastrophic Antiphospholipid Syndrome Market Forward?

    The surging incidence of autoimmune disorders is set to drive the catastrophic antiphospholipid syndrome market’s growth. Autoimmune disorders, conditions caused by an overactive immune response attacking healthy cells and tissues in the body, are on the rise partly due to increased exposure to pollutants that interfere with the normal functioning of the immune system and cause unconventional immune reactions. The progression of autoimmune disorders fuels the development of catastrophic antiphospholipid syndrome by stimulating the array of antiphospholipid antibodies, which causes extensive blood clotting and multi-organ failure. For instance, the Crohn’s and Colitis Foundation of Canada reported in June 2023 that there were 322,600 individuals diagnosed with inflammatory bowel disease in 2023 in Canada, a number projected to increase to 470,000 by 2035, with annual new cases growing from 11,000 to 14,000. Therefore, the growth of the catastrophic antiphospholipid syndrome market is being accelerated by the rise in autoimmune disorders. The escalating healthcare expenditure is poised to fuel the growth of the catastrophic antiphospholipid syndrome market. Healthcare expenditure entails total financial resources invested in health services, goods, and public health activities by private individuals, government bodies, and organizations. The spending on healthcare is increasing due to the aging population, which typically requires more regular and intensive health services. This healthcare expenditure augments the catastrophic antiphospholipid syndrome market’s growth by making advanced diagnostics, intensive care, and essential treatments such as anticoagulation therapy, immunosuppressants, and plasmapheresis more accessible. For instance, provisional estimates by the Office for National Statistics in May 2023 indicated that the UK’s healthcare expenditure hit roughly $331.70 billion (£283 billion) in 2022, recording a nominal increase of 0.7% compared to 2021. Therefore, the mounting healthcare expenditure is propelling the growth of the catastrophic antiphospholipid syndrome market.

    How Is The Catastrophic Antiphospholipid Syndrome Market Organized By Different Segments?

    The catastrophic antiphospholipid syndrome market covered in this report is segmented –

    1) By Treatment: Anticoagulants, Immunosuppressive Therapy, Plasma Exchange Therapy (Plasmapheresis), Intravenous Immunoglobulin (IVIG), Other Treatments

    2) By Route Of Administration: Oral, Parenteral

    3) By Diagnostic Tools: Blood Testing, Imaging Techniques, Genetic Testing

    4) By End-User: Hospitals, Specialty clinics, Ambulatory surgical centers, Other End-Users

    Subsegments:

    1) By Anticoagulants: Heparin, Low Molecular Weight Heparin (LMWH), Warfarin, Direct Oral Anticoagulants (DOACs), Fondaparinux

    2) By Immunosuppressive Therapy: Corticosteroids, Cyclophosphamide, Azathioprine, Mycophenolate Mofetil, Methotrexate

    3) By Plasma Exchange Therapy (Plasmapheresis): Therapeutic Plasma Exchange (Tpe), Double Filtration Plasmapheresis (Dfpp), Centrifugal Plasmapheresis, Membrane-Based Plasmapheresis

    4) By Intravenous Immunoglobulin (Ivig): Standard Intravenous Immunoglobulin (Ivig), High-Dose Intravenous Immunoglobulin (Ivig), Liquid Intravenous Immunoglobulin (Ivig), Lyophilized Intravenous Immunoglobulin (Ivig)

    5) By Other Treatments: Monoclonal Antibodies, Complement Inhibitors, Antiplatelet Agents, Anti-Tumor Necrosis Factor (Tnf) Agents, Organ Support Therapies

    Who Are The Primary Market Leaders In The Catastrophic Antiphospholipid Syndrome Market?

    Major companies operating in the catastrophic antiphospholipid syndrome market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC., Abbott Laboratories, Novartis AG., Fresenius Kabi AG., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Apotex Inc., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Limited, LEO Pharma A/S, Kedrion Biopharma Inc., Amphastar Pharmaceuticals Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/catastrophic-antiphospholipid-syndrome-global-market-report

    How Do Regional Dynamics Influence The Catastrophic Antiphospholipid Syndrome Market Performance?

    North America was the largest region in the catastrophic antiphospholipid syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the catastrophic antiphospholipid syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25718&type=smp

    Browse Through More Reports Similar to the Global Catastrophic Antiphospholipid Syndrome Market 2025, By The Business Research Company

    Hypolipidemics Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report

    Lipid Disorder Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

    Cardiometabolic Diseases Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Factors Will Push The Ambulance Stretchers Market To Achieve $3.5 Billion By 2029?

    Which Factors Will Push The Ambulance Stretchers Market To Achieve $3.5 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Projected Valuation Of The Ambulance Stretchers Market In The Coming Years?

    The dimension of the ambulance stretcher market has significantly expanded over the past few years. The market is projected to escalate from a value of $2.07 billion in 2024 to approximately $2.21 billion by 2025, with an impressive Compound Annual Growth Rate (CAGR) of 6.9%. Numerous factors contribute to this historic growth such as heightened demand for patient safety and comfort, increased consciousness regarding pre-hospital emergency medical assistance, escalating urban growth and traffic gridlocks, elevated occurrence of natural calamities and large-scale emergencies, and an overall inflating healthcare expenditure.

    The market size for ambulance stretchers is anticipated to witness robust growth in the coming years, reaching a valuation of $2.84 billion by 2029 with a CAGR of 6.5%. This forthcoming surge in the projected era can be linked with the increasing need for emergency medical services, a growing elderly populace, a rising incidence of chronic diseases, an escalation in ambulance fleet numbers, and high investments in healthcare infrastructure. Highlights of the anticipated trends within this period comprise of advancements in stretcher design technology, the incorporation of electronic lifting mechanisms, progress in lightweight composite materials, improvements in foldable and space-saving stretcher systems, and the introduction of technology-enabled remote patient monitoring features.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25691&type=smp

    Which Growth Drivers Are Shaping The Ambulance Stretchers Market Outlook?

    The anticipated growth of the ambulance stretchers market is driven by the increasing frequency of road accidents. These accidents, often unforeseen events or crashes on roads involving one or more vehicles, can lead to physical harm, loss of life, or damage to property. Distractions caused by mobile phone usage while driving escalate the likelihood of accidents, given it divides the driver’s focus. Ambulance stretchers play a key role in these scenarios, ensuring that those injured are safely and efficiently transported from the accident scene to medical facilities. This limits further injuries and allows for immediate medical action. A report from the Transport Accident Commission, a government agency in Australia, revealed that in June 2024, 289 lives were claimed on roads in Victoria, a rise of 8.6% or 23 more deaths than the same period, the prior year. Therefore, the escalating rate of road accidents acts as a catalyst in the expansion of the ambulance stretchers market.

    What Is The Segment Breakdown Of The Ambulance Stretchers Market?

    The ambulance stretchers market covered in this report is segmented –

    1) By Type: Manual Stretchers, Electric Stretchers, Foldable Stretchers, Stretcher Chairs

    2) By Technology: Non-Motorized, Motorized

    3) By Material: Aluminum, Steel, Plastic, Composite Materials

    4) By End Users: Emergency Medical Service Providers, Hospitals, Ambulatory Service Centers, Other End-Users

    Subsegments:

    1) By Manual Stretchers: Wheeled Stretchers, Non-wheeled Stretchers, Scoop Stretchers, Basket Stretchers

    2) By Electric Stretchers: Hydraulic Electric Stretchers, Battery-powered Electric Stretchers, Adjustable Height Electric Stretchers, Self-loading Electric Stretchers

    3) By Foldable Stretchers: Canvas Foldable Stretchers, Aluminum Foldable Stretchers, Pole-Type Foldable Stretchers, Spinal Board Foldable Stretchers

    4) By Stretcher Chairs: Convertible Stretcher Chairs, Stair Climbing Stretcher Chairs, Foldable Stretcher Chairs, Transport Wheelchair Stretchers

    How Are Global Trends Impacting The Development Of The Ambulance Stretchers Market?

    Leading businesses in the ambulance stretcher market are emphasizing on innovating advanced solutions such as self-loading electric stretchers. The objective is to augment patient safety, minimize manual interference by emergency workers, and optimize efficiency during patient relocation. A self-loading electric stretcher signifies a motorized patient transportation equipment with an integrated loading and unloading system. This enables the stretcher to hoist and load itself into an ambulance, eliminating the need for manual lifting by healthcare employees. In December 2023, KARTSANA, S.L., a renowned manufacturing firm based in Spain, introduced the superbrava electric stretcher to boost efficiency and safety in patient handling. The product ensures robustness, safety, and controllability, equipped with a hydraulic hoisting system that can bear up to 320 kg and adaptable multi-position handrails for the comfort and security of the patient. The design aids in seamless, safe patient movement, reducing the burden of emergency medical professionals in critical scenarios.

    Who Are The Major Stakeholders Operating In The Ambulance Stretchers Market?

    Major companies operating in the ambulance stretchers market are Medline Industries LP, Stryker Corporation, Baxter International Inc., Hill-Rom Holdings Inc., Hebei Pukang Medical Instruments Co. Ltd., Ferno-Washington Inc., Spencer Italia S.r.l., Narang Medical Limited, Advin Health Care, Kartsana Medical GmbH, IndoSurgicals Private Limited, Frima Concept SARL, Dragon Industry Co. Ltd., PVS S.p.A., Desco Medical India, Fu Shun Hsing Technology Co. Ltd., Besco Medical Limited, Red Leaf Medical Inc., Sarvottam Appliances Private Limited, EMS Mobil Sistemler A.S

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/ambulance-stretchers-global-market-report

    Which Region Is Likely To Register The Fastest Growth In The Ambulance Stretchers Market?

    North America was the largest region in the ambulance stretchers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ambulance stretchers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25691&type=smp

    Browse Through More Reports Similar to the Global Ambulance Stretchers Market 2025, By The Business Research Company

    Air Ambulance Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/air-ambulance-services-global-market-report

    Air Ambulance Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/air-ambulance-services-global-market-report

    Emergency Medical Services Products Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/emergency-medical-services-products-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Emerging Trends Are Driving The Anti-D Immunoglobulin Market Toward $3.34 Billion By 2029?

    Which Emerging Trends Are Driving The Anti-D Immunoglobulin Market Toward $3.34 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What CAGR And Valuation Are Anticipated For The Anti-D Immunoglobulin Market?

    Recent years have seen a substantial upswing in the size of the anti-D immunoglobulin market. Its projected growth from $2.42 billion in 2024 to $2.59 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%, reflects this trend. The increase in the historic period can be credited to heightened awareness about the risks of rhesus incompatibility, the expansion of national immunization programs, the introduction of maternal and neonatal health policies, an increase in global birth rates, and the rise in blood transfusion procedures.

    In the coming years, the anti-D immunoglobulin market is projected to witness robust expansion, anticipating to reach a market value of $3.34 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. The spur in growth during the forecast period can be ascribed to the growing demand for prenatal and postnatal care, enhanced focus towards maternal health in developing and transition economies, increments in healthcare infrastructure capital, the expansion of global health coverage programs, and regulatory support for immunoglobulin treatment modalities. Key trends that can be seen during the projected period include advancements in plasma segmentation technology, the emergence of recombinant antibody alternatives, growth in automation within immunoglobulin production, the utilization of high-purity formulation methodologies, and the incorporation of cold chain surveillance systems.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25694&type=smp

    What Core Drivers Are Expected To Influence The Anti-D Immunoglobulin Market?

    The surge in birth rates is anticipated to drive the growth of the anti-D immunoglobulin market. Birth rates, which depict the number of live births per 1,000 individuals annually, are on the rise due to limited access to education and family planning facilities, leading to higher fertility rates and increased family sizes. Anti-D immunoglobulin aids this increase in birth rates by averting Rh incompatibility during pregnancy, mitigating the risk of hemolytic disease in newborns and promoting healthier pregnancy outcomes in the future. As an example, the Centers for Disease Control and Prevention, a government agency based in the US, reported 3,622,673 births in 2024 in April 2025, marking a 1% growth from the preceding year. Thus, the growth in birth rates is a significant contributor to the upswing of the anti-D immunoglobulin market. The growth in healthcare infrastructure, due to better access to maternal care services, is also expected to fuel the growth of the anti-D immunoglobulin market. This infrastructure, which encompasses facilities, equipment, personnel, and supporting structures necessary to deliver healthcare services within a population, is expanding due to a growing global population, subsequently spurring a greater demand for medical care and necessitating the establishment of additional hospitals, clinics, and more. The growth of healthcare infrastructure improves access to maternal care, permitting effective screening and timely administration of anti-D immunoglobulin, thus reducing the risk of hemolytic disease in newborns. For instance, the Department of Health and Social Care, a government organization based in the UK, unveiled plans in May 2023 to invest over $27 billion (£20 billion) in developing new hospital facilities. Under the New Hospital Programme, two hospitals are already operational, five are under construction, and over 20 are projected to be in progress or completed by the end of the following year. Consequently, the growth of healthcare infrastructure is greatly influencing the expansion of the anti-D immunoglobulin market.

    What Are The Main Segment Classifications In The Anti-D Immunoglobulin Market?

    The anti-d immunoglobulin market covered in this report is segmented –

    1) By Product Type: Intramuscular Anti-D Immunoglobulin, Intravenous Anti-D Immunoglobulin

    2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

    3) By Application: Hemolytic Disease Of The Newborn, Immune Thrombocytopenic Purpura, Antenatal And Postnatal Prophylaxis, Other Applications

    4) By End-User: Hospitals, Clinics, Blood Banks, Research Laboratories

    Subsegments:

    1) By Intramuscular Anti-D Immunoglobulin: Standard Dose, High Dose, Pre-Filled Syringes, Vials

    2) By Intravenous Anti-D Immunoglobulin: Lyophilized Powder, Liquid Formulation, Single-Use Vials, Multi-Dose Vials

    How Are Industry Trends Steering The Expansion Of The Anti-D Immunoglobulin Market?

    Prominent businesses in the anti-D immunoglobulin market are prioritizing the creation of cutting-edge solutions like recombinant anti-D immunoglobulin. The goal is to widen the reach of safe and reliable prophylaxis for Rh-negative pregnant individuals and enhance maternal health outcomes. Recombinant anti-D immunoglobulin is a laboratory-developed monoclonal antibody aimed at preventing Rh incompatibility among Rh-negative people. It offers a superior alternative to plasma-derived anti-D treatments because it boasts improved consistency, safety, and scalability. For example, in January 2022, an Indian biopharmaceutical firm named Bharat Serums and Vaccines (BSV), debuts the world’s first commercially available recombinant anti-Rho (D) immunoglobulin. This product utilizes innovative recombinant technology, boosting the dependability of the product and lessening variability linked with plasma-derived alternatives. This product is particularly noteworthy in areas with high Rh-negative pregnancy rates as it refines preventive healthcare and lowers the possibility of newborns developing hemolytic disease.

    Which Companies Are Contributing Significantly To The Anti-D Immunoglobulin Market Growth?

    Major companies operating in the anti-d immunoglobulin market are Merck Group, Bayer AG, CSL Behring, Baxter International Inc., Intas Pharmaceuticals Ltd., Octapharma AG, Zydus Lifesciences Limited, Emergent BioSolutions Inc., Kedrion Biopharma Inc., Biotest AG, Sanquin, Taj Pharmaceuticals Limited, Kamada Pharmaceuticals, Bharat Serums and Vaccines Limited, Saol Therapeutics Inc., Aetos Pharma Private Limited, Avin Darou, PV Pharma Healthcare Pvt. Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Ocean Pharmacoat Pvt. Ltd.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/anti-d-immunoglobulin-global-market-report

    Which Region Holds The Greatest Opportunity For Anti-D Immunoglobulin Market Expansion?

    North America was the largest region in the anti-D immunoglobulin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-d immunoglobulin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25694&type=smp

    Browse Through More Reports Similar to the Global Anti-D Immunoglobulin Market 2025, By The Business Research Company

    Immunotoxin Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/immunotoxin-global-market-report

    Autoimmune Treatment Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

    Mammalian Polyclonal Immunoglobulin G Igg Antibody Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/mammalian-polyclonal-immunoglobulin-g-igg-antibody-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Which Factors Will Push The Ambulance Stretchers Market To Achieve $3.5 Billion By 2029?

    Which Factors Will Push The Ambulance Stretchers Market To Achieve $3.5 Billion By 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Is The Projected Valuation Of The Ambulance Stretchers Market In The Coming Years?

    The dimension of the ambulance stretcher market has significantly expanded over the past few years. The market is projected to escalate from a value of $2.07 billion in 2024 to approximately $2.21 billion by 2025, with an impressive Compound Annual Growth Rate (CAGR) of 6.9%. Numerous factors contribute to this historic growth such as heightened demand for patient safety and comfort, increased consciousness regarding pre-hospital emergency medical assistance, escalating urban growth and traffic gridlocks, elevated occurrence of natural calamities and large-scale emergencies, and an overall inflating healthcare expenditure.

    The market size for ambulance stretchers is anticipated to witness robust growth in the coming years, reaching a valuation of $2.84 billion by 2029 with a CAGR of 6.5%. This forthcoming surge in the projected era can be linked with the increasing need for emergency medical services, a growing elderly populace, a rising incidence of chronic diseases, an escalation in ambulance fleet numbers, and high investments in healthcare infrastructure. Highlights of the anticipated trends within this period comprise of advancements in stretcher design technology, the incorporation of electronic lifting mechanisms, progress in lightweight composite materials, improvements in foldable and space-saving stretcher systems, and the introduction of technology-enabled remote patient monitoring features.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=25691&type=smp

    Which Growth Drivers Are Shaping The Ambulance Stretchers Market Outlook?

    The anticipated growth of the ambulance stretchers market is driven by the increasing frequency of road accidents. These accidents, often unforeseen events or crashes on roads involving one or more vehicles, can lead to physical harm, loss of life, or damage to property. Distractions caused by mobile phone usage while driving escalate the likelihood of accidents, given it divides the driver’s focus. Ambulance stretchers play a key role in these scenarios, ensuring that those injured are safely and efficiently transported from the accident scene to medical facilities. This limits further injuries and allows for immediate medical action. A report from the Transport Accident Commission, a government agency in Australia, revealed that in June 2024, 289 lives were claimed on roads in Victoria, a rise of 8.6% or 23 more deaths than the same period, the prior year. Therefore, the escalating rate of road accidents acts as a catalyst in the expansion of the ambulance stretchers market.

    What Is The Segment Breakdown Of The Ambulance Stretchers Market?

    The ambulance stretchers market covered in this report is segmented –

    1) By Type: Manual Stretchers, Electric Stretchers, Foldable Stretchers, Stretcher Chairs

    2) By Technology: Non-Motorized, Motorized

    3) By Material: Aluminum, Steel, Plastic, Composite Materials

    4) By End Users: Emergency Medical Service Providers, Hospitals, Ambulatory Service Centers, Other End-Users

    Subsegments:

    1) By Manual Stretchers: Wheeled Stretchers, Non-wheeled Stretchers, Scoop Stretchers, Basket Stretchers

    2) By Electric Stretchers: Hydraulic Electric Stretchers, Battery-powered Electric Stretchers, Adjustable Height Electric Stretchers, Self-loading Electric Stretchers

    3) By Foldable Stretchers: Canvas Foldable Stretchers, Aluminum Foldable Stretchers, Pole-Type Foldable Stretchers, Spinal Board Foldable Stretchers

    4) By Stretcher Chairs: Convertible Stretcher Chairs, Stair Climbing Stretcher Chairs, Foldable Stretcher Chairs, Transport Wheelchair Stretchers

    How Are Global Trends Impacting The Development Of The Ambulance Stretchers Market?

    Leading businesses in the ambulance stretcher market are emphasizing on innovating advanced solutions such as self-loading electric stretchers. The objective is to augment patient safety, minimize manual interference by emergency workers, and optimize efficiency during patient relocation. A self-loading electric stretcher signifies a motorized patient transportation equipment with an integrated loading and unloading system. This enables the stretcher to hoist and load itself into an ambulance, eliminating the need for manual lifting by healthcare employees. In December 2023, KARTSANA, S.L., a renowned manufacturing firm based in Spain, introduced the superbrava electric stretcher to boost efficiency and safety in patient handling. The product ensures robustness, safety, and controllability, equipped with a hydraulic hoisting system that can bear up to 320 kg and adaptable multi-position handrails for the comfort and security of the patient. The design aids in seamless, safe patient movement, reducing the burden of emergency medical professionals in critical scenarios.

    Who Are The Major Stakeholders Operating In The Ambulance Stretchers Market?

    Major companies operating in the ambulance stretchers market are Medline Industries LP, Stryker Corporation, Baxter International Inc., Hill-Rom Holdings Inc., Hebei Pukang Medical Instruments Co. Ltd., Ferno-Washington Inc., Spencer Italia S.r.l., Narang Medical Limited, Advin Health Care, Kartsana Medical GmbH, IndoSurgicals Private Limited, Frima Concept SARL, Dragon Industry Co. Ltd., PVS S.p.A., Desco Medical India, Fu Shun Hsing Technology Co. Ltd., Besco Medical Limited, Red Leaf Medical Inc., Sarvottam Appliances Private Limited, EMS Mobil Sistemler A.S

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/ambulance-stretchers-global-market-report

    Which Region Is Likely To Register The Fastest Growth In The Ambulance Stretchers Market?

    North America was the largest region in the ambulance stretchers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ambulance stretchers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=25691&type=smp

    Browse Through More Reports Similar to the Global Ambulance Stretchers Market 2025, By The Business Research Company

    Air Ambulance Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/air-ambulance-services-global-market-report

    Air Ambulance Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/air-ambulance-services-global-market-report

    Emergency Medical Services Products Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/emergency-medical-services-products-global-market-report

    About The Business Research Company:

    With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Emerging Trends and Growth Drivers in the Disruptive Behavior Disorder Treatment Market Through 2029

    Emerging Trends and Growth Drivers in the Disruptive Behavior Disorder Treatment Market Through 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Outlook for the Disruptive Behavior Disorder Treatment Market Heading Into 2029?

    There’s been a robust growth in the size of the disruptive behavior disorder treatment market in the past few years. The market is set to expand from a value of $1.52 billion in 2024 to an estimated $1.62 billion in 2025, representing a compound annual growth rate (CAGR) of 6.1%. Several factors have contributed to this surge during the historical period, such as increased incidences of drug abuse, a rise in mental disorders amongst children, a growing preference for online shopping among consumers, higher rates of diagnosis, and an increase in cases of oppositional defiant disorder.

    In the upcoming years, the market for treatment of disruptive behavior disorders is projected to experience significant expansion. With a Compound Annual Growth Rate (CAGR) of 5.9%, the market is predicted to reach a value of $2.03 billion by 2029. Factors such as increasing cases of disruptive behavior disorder, the subsequent rise in awareness and diagnosis rates, enhanced governmental interventions, escalating healthcare demands, and proliferating campaign numbers contribute to the expected growth during the forecast period. Noteworthy trends in the forthcoming period include digital therapeutics, telepsychiatry platforms, wearable devices for mental health, mobile health applications, therapy through virtual reality, remote parent training tools, and the application of machine learning for diagnosing disorders.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24522&type=smp

    Which Factors Are Pushing The Disruptive Behavior Disorder Treatment Market Forward?

    Anticipated growth in the disruptive behavior disorder treatment market is predicted to be fueled by a growing prevalence of mental illness. Mental illnesses constitute a range of conditions that impact mood, thinking, behavior, and functionality. Increased chronic stress levels are contributing to a rise in these illnesses, as long-term stress negatively affects brain function and can cause or escalate mental health disorders. The treatment of disruptive behavior disorders plays a crucial role in managing mental illness, particularly among children and adolescents, by addressing ongoing behavioral problems, thus underlining the importance of early intervention. It promotes emotional stability and proper social dynamics through focused therapies, leading to better mental health results. For instance, the National Institute of Mental Health reported in 2022 that 59.3 million adults aged 18 and older in the US suffered from any mental illness (AMI), constituting 23.1% of the total adult population. This rising incidence of mental illness is therefore driving the disruptive behavior disorder treatment market’s growth. Higher healthcare spending is spurring the growth of the market, thanks to increased investments in mental health infrastructure and early intervention programs. Healthcare expenditure encompasses all financial outlays on medical services, treatments, facilities, research, and public health efforts aimed at sustaining or boosting health outcomes. The need for more medical care, treatment, and long-term health services due to an aging population has led to increased healthcare spending. This expanded expenditure translates into better disruptive behavior disorder treatment as it facilitates access to specialized therapies, medications, and early intervention services. It also enables the development of advanced treatment programs, improving mental health outcomes, and overall care quality. For instance, the Centers for Medicare & Medicaid Services (CMS) reported in December 2024 that national health expenditures (NHE) had grown by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of GDP. Consequently, increased healthcare spending is fueling growth in the disruptive behavior disorder treatment market.

    Which Segment Held The Largest Share In The Disruptive Behavior Disorder Treatment Market In 2025?

    The disruptive behavior disorder treatment market covered in this report is segmented –

    1) By Type: Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder

    2) By Treatment: Medication Management, Comprehensive Evaluation, Family Therapy, Parenting Modification, Group Therapy, Individual Therapy, Social And Emotional Skills Training

    3) By Age Group: Children 4 To 12 Years, Adolescents 13 To 17 Years, Young Adults 18 To 24 Years, Adults 25 Years And Above

    4) By End User: Hospitals, Outpatient Clinics, Residential Treatment Facilities, Home Care Settings, Specialized Disruptive Behavior Disorder Treatment Centers

    Subsegments:

    1) By Oppositional Defiant Disorder: Mild Oppositional Defiant Disorder, Moderate Oppositional Defiant Disorder, Severe Oppositional Defiant Disorder

    2) By Conduct Disorder: Childhood-Onset Conduct Disorder, Adolescent-Onset Conduct Disorder, Unspecified Onset Conduct Disorder

    3) By Intermittent Explosive Disorder: Frequent Low-Intensity Explosive Episodes, Infrequent High-Intensity Explosive Episodes, Mixed Severity Explosive Episodes

    Which Organizations Are Driving Progress In The Disruptive Behavior Disorder Treatment Industry?

    Major companies operating in the disruptive behavior disorder treatment market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co. Ltd., Nationwide Children’s Hospital, Seattle Children’s Hospital, Children’s Hospital of Philadelphia, Hikma Pharmaceuticals, Boston Children’s Hospital, Children’s Hospital of Wisconsin, Stanford Medicine Children’s Health, Children’s Hospital New Orleans, Sunovion Pharmaceuticals Inc., Piney Ridge Treatment Center, Village Behavioral Health

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/disruptive-behavior-disorder-treatment-global-market-report

    Which Region Is Expected To Experience The Highest Growth In The Disruptive Behavior Disorder Treatment Industry?

    North America was the largest region in the disruptive behavior disorder treatment market in 2024. The regions covered in the disruptive behavior disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24522&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Industry Forecast: Digital Health And Wellness Market to Generate $1310.07 Billion Revenue by 2029

    Industry Forecast: Digital Health And Wellness Market to Generate $1310.07 Billion Revenue by 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Much Is the Global Digital Health And Wellness Market Valued at Present and by 2029?

    In the past few years, the market size for digital health and wellness has experienced significant expansion. The market, which will increase from $455.34 billion in 2024 to $563.53 billion in 2025, expects an annual compound growth rate (CAGR) of 23.8%. Factors leading to the growth observed in the historic period include a rising trend in chronic illnesses, an increase in demand for remote monitoring solutions, the growing adoption of telemedicine and virtual meetings for healthcare, the increased availability of health data from the Internet of Things (IoT) devices for tailored treatment, and a rising demand for mental health and wellness platforms.

    Anticipations suggest a robust surge in the digital health and wellness market size in the forthcoming years, with an estimated value of $1310.07 billion by 2029, implying a compound annual growth rate (CAGR) of 23.5%. The upswing during the forecast period is linked to the upsurge in consumer enthusiasm towards bespoke healthcare solutions, increasing usage of health-centric mobile applications and wearable gadgets, escalating consciousness about preventive health and wellbeing, coupled with government’s increasing backing and investments for digital healthcare ventures. Noteworthy trends within the forecast span encompass enhancements in wearable health tech and intelligent devices, realization of artificial intelligence (AI) in diagnostics and therapy planning, progress in telemedicine platforms for virtual consultations, technological leaps in health data interpretation for customized care, and the incorporation of the Internet of Things (IoT) in healthcare for contemporaneous observation.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24520&type=smp

    #What Drivers Are Influencing Growth In The Digital Health And Wellness Market?

    The increasing occurrence of long-term health conditions is anticipated to fuel the expansion of the digital health and wellness industry. Chronic diseases are long-lasting health issues that develop gradually and persist over a long duration, often necessitating ongoing medical care. The escalating incidence of chronic diseases is partly due to sedentary lifestyles, where extended periods of sitting and insufficient physical activity increase the chances of illnesses like heart diseases and diabetes. Digital health and wellness tools assist in managing chronic diseases by providing constant monitoring and tailor-made care plans, simplifying health tracking for patients. It minimizes hospital visits by facilitating remote consultations and early interventions, thereby enhancing the overall quality of life. For instance, the National Health Service reported in June 2024, that 3,615,330 individuals registered with a general practitioner (GP) were identified to have non-diabetic hyperglycemia or pre-diabetes (a condition characterized by raised blood sugar levels, but not at a level enough to be considered as diabetes) in 2023, reflecting an 18% growth from the 3,065,825 cases noted in 2022. Consequently, the escalating incidence of chronic diseases is propelling the expansion of the digital health and wellness industry.

    What Are The Main Segments Identified In The Digital Health And Wellness Market Research?

    The digital health and wellness market covered in this report is segmented –

    1) By Type: Software, Service, Hardware

    2) By Consumer Health Devices: Wearable Devices, Smart Health Monitors, Mobile Health Applications, Remote Patient Monitoring Devices, Fitness Trackers

    3) By Digital Therapeutics: Prescription Digital Therapeutics, Behavioral Intervention Apps, Chronic Disease Management Software, Mental Health Support Programs, Substance Abuse Treatment Tools

    4) By Application: Clinics, Hospitals, Ambulatory Surgery Centres, Home Care Settings, Other Applications

    5) By End-User: Healthcare Providers, Patients, Payers, Other End-Users

    Subsegments:

    1) By Software: mHealth Apps, Population Health Management, Electronic Health Records (EHR), Clinical Decision Support Systems (CDSS)

    2) By Service: Health Coaching Services, Digital Therapeutics Support Services, Remote Monitoring Services, Virtual Care Services

    3) By Hardware: Telemedicine Kiosks, Diagnostic Devices, Smart Medical Devices, Mobile Health Devices

    What Are The Leading Trends And Opportunities In The Digital Health And Wellness Sector?

    Prominent organizations in the digital health and wellness sector are working towards breakthroughs in healthcare via the advancement of digital health and wellness platforms to improve health surveillance and patient results. These platforms encompass a broad system that uses technology such as applications, wearable devices, and data analysis to boost health monitoring, disease control, and overall wellness. For example, in February 2023, Albertsons Companies Inc., a grocery store corporation in the US, introduced Sincerely Health, an all-encompassing digital health and wellness platform. This forward-thinking solution is aimed at enabling customers to manage their health through tailored health advice, tracking of goals and activities, dietary and lifestyle recommendations, and a reward system encouraging healthy habits. Sincerely Health also incorporates pharmacy services and virtual health consultations, offering a smooth and readily available health management experience.

    Which Companies Play A Key Role In The Development Of The Digital Health And Wellness Market?

    Major companies operating in the digital health and wellness market are Apple Inc., Google LLC, Samsung Electronics Co. Ltd., Microsoft Corporation, International Business Machines Corporation, Siemens Healthineers AG, Philips Healthcare, GE HealthCare Technologies Inc., Cerner Corporation, Garmin International Inc., Drägerwerk AG & Co. KGaA, ResMed Inc., Epic Systems Corporation, Teladoc Health, Masimo Corp., Athenahealth Inc., Veradigm, Johnson & Johnson Health and Wellness Solutions Inc., Headspace Inc., Fitbit Inc., Omada Health, Virgin Pulse Inc., WellDoc Inc., Vivify Health Inc., NXGN Management LLC.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/digital-health-and-wellness-global-market-report

    What Are The Key Regional Developments Shaping The Digital Health And Wellness Market?

    North America was the largest region in the digital health and wellness market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital health and wellness market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24520&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Future Projections: Celiac Disease Market to Reach $1.15 Billion by 2029 at 10.1% CAGR

    Future Projections: Celiac Disease Market to Reach $1.15 Billion by 2029 at 10.1% CAGR

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What CAGR Is Anticipated for the Celiac Disease Market Through 2029?

    The market size for celiac disease has witnessed a significant expansion in the past few years. The market is set to surge from $0.71 billion in 2024 to $0.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.4%. Factors contributing to this growth during the historic period include an increased incidence of celiac disease, greater awareness of disorders related to gluten, enhanced research funding towards autoimmune diseases, a spike in food allergies and sensitivities, and a heightened level of health consciousness among consumers.

    In the coming years, the celiac disease market is expected to undergo swift growth, reaching a size of $1.15 billion in 2029, with a compound annual growth rate of 10.1%. The growth anticipated in this forecast period can be accredited to a surge in demand for custom-made medicine, improvements in healthcare infrastructure, a growing need for nutritional counseling services, an increase in child diagnosis rates, and emphasis on early childhood screening and prevention. Notable trends within this period are the presence of diagnostic testing, developments in genetic testing technologies, enhanced primary care screening protocols, technological advancements in ELISA and serological testing, and the use of non-invasive diagnostic methods.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

    What Market Forces Are Driving The Celiac Disease Sector In 2025 And Beyond?

    The evolution of personalized medicine is anticipated to catalyze the expansion of the celiac disease market in the future. Tailoring healthcare to align with a person’s genetic makeup, surroundings, and lifestyle defines personalized medicine. The surge in demand for this kind of tailored medicine is caused by the advancements in genetic testing, which paves the way for more precise diagnoses and treatments designed to cater to unique patient needs. Personalized medicine boosts celiac disease treatment by providing exact identification of genetic indicators and individual immune responses, which results in more specific and effective treatment strategies for each patient. For example, in February 2024, the Personalized Medicine Coalition, a nonprofit organization based in the US, reported that the FDA had greenlit 16 personalized therapies in 2023, focusing on rare diseases, which signified an increase from the 6 approved in 2022. Consequently, the evolution of personalized medicine will stimulate the expansion of the celiac disease market.

    How Is The Global Celiac Disease Market Categorized By Segments?

    The celiac disease market covered in this report is segmented –

    1) By Treatment: Infliximab, Larazotide Acetate, Gluten Free Diet, Other Treatments

    2) By Route Of Administration: Oral, Parenteral

    3) By End Users: Hospitals, Homecare, Other End-Users

    Subsegments:

    1) By Infliximab: Biosimilar Infliximab, Branded Infliximab, Intravenous Administration, Hospital-Based Usage, Off-Label Use In Refractory Celiac Disease,

    2) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

    3) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

    4) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

    What Long-Term Trends Are Likely To Affect The Celiac Disease Market?

    Leading firms in the celiac disease market are concentrating on the creation of innovative solutions, such as anti-interleukin-15 (IL-15) antibodies, which help in mitigating tissue injury by controlling excessive immune cell activity. Anti-interleukin-15 (IL-15) antibodies, special types of proteins, impede the functionality of IL-15 cytokine, thus putting a check on the activity of the immune system and inflammation. For instance, in May 2025, the U.S. Food and Drug Administration gave Fast Track status to TEV-53408, an experimental anti-interleukin-15 (IL-15) antibody, launched by Teva Pharmaceutical Industries, a pharmaceutical corporation based in Israel. This exploratory monoclonal antibody, designed especially for individuals with celiac disease who continue to maintain a gluten-free diet, operates by impeding interleukin-15 (IL-15), a substance that sets off the immune reaction leading to intestinal damage in patients with celiac disease. Currently, the safety and efficacy of this treatment option are being examined in a Phase 2a clinical trial.

    Which Firms Are Considered Leaders In The Celiac Disease Market Space?

    Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

    What Role Do Regional Policies And Investments Play In Celiac Disease Market Expansion?

    North America was the largest region in the celiac disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24497&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • 2025–2029 Anhydrous Lactose Market Outlook: Regional Trends and Growth Forecast

    2025–2029 Anhydrous Lactose Market Outlook: Regional Trends and Growth Forecast

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Does the Forecast Indicate for the Anhydrous Lactose Market From 2025 to 2029?

    In the last few years, the anhydrous lactose market has seen significant expansion. The market is set to increase from $1.17 billion in 2024 to $1.24 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The historical growth of this market is due to factors such as increasing demand for infant formula production, growth in the pharmaceutical excipient industry, more extensive dairy processing operations, an upsurge in the confectionery and bakery usage, and advancements in the food formulations industry’s shelf-stability requirements.

    In the ensuing years, a substantial growth is anticipated in the market size of anhydrous lactose, escalating to $1.56 billion in 2029 with an annual compound growth rate (CAGR) of 5.8%. The predicted growth in the coming period is due to factors such as the increasing use in sports nutrition and dietary supplements, burgeoning investments in pharmaceutical research and expansions in lactose-free and modified lactose products. Additional contributing elements involve technological progress in lactose refinement and elevating demand in emerging economies. The upcoming period will also witness increased demand for pharmaceutical-grade lactose, improvements in lactose cleansing technology, the expanding application in infant formula, and nutritional products along with the growth of lactose-based excipients for regulated drug release. There’s also a rising trend of using anhydrous lactose in the food and beverage industry to enhance texture.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24461&type=smp

    What Elements Are Contributing To Growth In The Anhydrous Lactose Market?

    The growth of the anhydrous lactose market is projected to be driven by the rise in pharmaceutical drug manufacturing. This systematic production process of drugs, under tight supervision, is done to ensure the safety, efficacy, and quality of medicines for treatment. The escalating numbers in the aging population are fueling the increase in pharmaceutical drug manufacturing due to an increased need for advanced treatments dealing with chronic diseases effectively. Anhydrous lactose is a go-to choice in pharmaceutical drug production, primarily serving as a filler and binder. The absence of moisture in it improves the durability and lifespan of tablets and capsules, thereby providing consistent drug delivery and quality. For instance, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing Europe’s pharmaceutical industry, reveals that the total production of pharmaceuticals in Europe reached €390,000 million ($422,803 million) in June 2023, showing an increase from €363,300 million ($393,857 million) in 2022. Consequently, the growth of the anhydrous lactose market is being propelled by the upsurge in pharmaceutical drug production.

    Which Segments Are Detailed In The Global Anhydrous Lactose Market Report?

    The anhydrous lactose market covered in this report is segmented –

    1) By Product Type: Edible Lactose, Pharmaceutical Lactose, Technical Lactose

    2) By Form: Powder, Granules, Tablets

    3) By Distribution Channel: Online Retail, Supermarkets Or Hypermarkets, Specialty Stores, Pharmacies

    4) By Application: Pharmaceutical Excipients, Lyophilized Products, Formula For Baby Food, Other Applications

    5) By End-User: Food Industry, Pharmaceutical Industry, Animal Feed Industry, Cosmetic Industry, Other End-Users

    Subsegments:

    1) By Edible Lactose: Infant Formula, Baked Goods, Confectionery, Dairy Products, Dietary Supplements

    2) By Pharmaceutical Lactose: Direct Compression Grade, Inhalation Grade, Granulation Grade, Spray-Dried Lactose

    3) By Technical Lactose: Animal Feed, Industrial Fermentation, Bioplastics, Cosmetics And Personal Care Products

    Which Emerging Trends And Strategic Shifts Are Shaping The Anhydrous Lactose Market?

    Leading players in the anhydrous lactose market are concentrating their efforts on creating innovative products such as inhalation-grade lactose to improve efficiency in the delivery of drugs for respiratory treatments. Inhalation-grade lactose, a pure form of lactose, is utilized as a medium in dry powder inhalers due to its uniform particle size and smooth flow. It facilitates the effective delivery of active pharmaceutical ingredients (API) to the lungs, providing accurate dosage and enhancing drug efficacy. For instance, DFE Pharma, a German-based firm that supplies pharma and nutraceutical excipient solutions, introduced Lactohale 400, a refined, anhydrous lactose, in July 2022. This addition expands DFE Pharma’s dry powder inhalation (DPI) range and is specifically designed for formulations that require decent flow with some stickiness, with a median particle size of 100 µm. The anhydrous attribute of Lactohale 400 sets it apart from traditional lactose monohydrate carriers, providing unique aerosolization performance and permitting personalization for particular pharmaceutical uses.

    Who Are The Key Contributors To Growth In The Anhydrous Lactose Market?

    Major companies operating in the anhydrous lactose market are Kerry Group, Sigma-Aldrich, Fagron Group, Spectrum Chemical Mfg. Corp., DFE Pharma, Wako Pure Chemical Industries Ltd., Anshul Life Sciences, Salius Pharma Pvt. Ltd., SimSon Pharma Limited, MEGGLE GmbH & Co. KG, VIVAN Life Science, Aurora Industry Co. Ltd, Glentham Life Sciences Limited, Lactalis Ingredients, Colorchem Industries Ltd., Jiangsu Dawning Phramaceutical Co. Ltd., International Ingredients & Excipients Pvt. Ltd., Fengchen Group Co. Ltd, Xi’an Harmonious Natural Biotechnology Co. Ltd., Hexon Laboratories Private Limited

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/anhydrous-lactose-global-market-report

    Which Region Is Projected To Lead The Anhydrous Lactose Market By 2025?

    North America was the largest region in the anhydrous lactose market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anhydrous lactose market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24461&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Comprehensive Forecast: Over-The-Counter (OTC) Sleep Aids Medication Market Share, Growth, and Opportunities Through 2029

    Comprehensive Forecast: Over-The-Counter (OTC) Sleep Aids Medication Market Share, Growth, and Opportunities Through 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Latest Market Insights for the Over-The-Counter (OTC) Sleep Aids Medication Industry?

    Recent years have witnessed significant expansion in the size of the over-the-counter (otc) sleep aids medication market. Projected to grow from $20.98 billion in 2024 to $22.69 billion in 2025, it boasts a compound annual growth rate (CAGR) of 8.2%. Factors contributing to this growth during the historic period include rising cases of insomnia, heightened awareness about sleep health, an increase in self-medication among consumers, the expansion of retail pharmacy chains, and a growing elderly population.

    The market size of over-the-counter (otc) sleep aids medication is projected to experience significant growth over the coming years, ballooning to $30.76 billion in 2029, with a compound annual growth rate (CAGR) of 7.9%. This growth within the forecast period is mainly attributed to the increasing demand for herbal and natural sleep aids, rising mental health conditions and stress-induced disorders, the growing use of digital health platforms for sleep tracking, the widespread collection of products on e-commerce platforms, and increased healthcare spending in emerging markets. Major trends within this forecast period include advancements in sleep aid formulation technologies, novel delivery systems such as gummies and sprays, advances in wearable sleep tracking technology, research and innovations in plant-based ingredients, and the utilization of artificial intelligence to create personalized sleep solutions.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24644&type=smp

    What Forces Are Driving The Growth Of The Over-The-Counter (OTC) Sleep Aids Medication Industry?

    The escalation in insomnia cases is projected to drive the over-the-counter (OTC) sleep aids medication market’s growth. Insomnia, a sleep disorder causing issues with falling asleep, maintaining sleep, or waking up prematurely, often leads to impoverished sleep quality and daytime dysfunction. Heightening stress levels due to job pressures and daily life struggles increase the occurrence of insomnia as they affect individuals’ ability to unwind and attain restful sleep. OTC sleep aid medicines deliver accessible, convenient relief for insomnia, aiding people in falling asleep quicker and enhancing their sleep quality, all without a prescription. For example, Oxford University Press, a UK-based publishing house, indicated in April 2024 that around 19.5% of adult females and 14.0% of adult males in the Americas, summing up to about 123 million people, suffered from insomnia in 2024. As a result, the surging incidences of insomnia are pushing the growth of the OTC sleep aids medication market.

    What Is The Overview Of Market Segmentation In The Over-The-Counter (OTC) Sleep Aids Medication Industry?

    The over-the-counter (OTC) sleep aids medication market covered in this report is segmented –

    1) By Type: Antihistamine, Melatonin Supplements, Herbal Supplement, Other Types

    2) By Application: Insomnia Treatment, Anxiety Relief, Other Applications

    3) By Distribution Channel: Online, Supermarkets Or Hypermarkets, Pharmacies and Drugstores, Specialty Stores

    Subsegments:

    1) By Antihistamine: Diphenhydramine-Based Sleep Aids, Doxylamine Succinate-Based Sleep Aids, Combination Sleep Aids

    2) By Melatonin Supplements: Immediate-Release Melatonin, Extended-Release Melatonin, Melatonin With Added Nutrients

    3) By Herbal Supplement: Valerian Root Supplements, Chamomile-Based Products, Passionflower Extracts, Lavender-Based Formulations, Multi-Herb Blends For Sleep

    4) By Other Types: Cannabidiol (CBD)-Based Sleep Aids, Amino Acid-Based Sleep Aids, Homeopathic Sleep Remedies, Aromatherapy Products

    What Future Market Trends Are Projected For The Over-The-Counter (OTC) Sleep Aids Medication Industry?

    Leading businesses in the OTC sleep aids medication market are concentrating their efforts on creating innovative solutions such as longevity-driven sleep optimization. This personalized method aims to enhance sleep quality, support enduring health, forestall chronic illnesses and extend lifespan. AgelessRx Inc., a longevity-oriented telehealth company originating from the U.S., for example, introduced a new sleep health program in November 2024. The program incorporates a prescription sleep aid, Trazodone, and a natural OTC supplement, Tran-Q Sleep, aimed at supporting all major aspects of sleep – quantity, quality, consistency and timing. This introduction signifies the company’s first venture into the sleep category using a personalized, scientifically-supported approach to enhance sleep as a key factor towards long-term health and longevity.

    Who Are The Primary Players Operating Across The Global Over-The-Counter (OTC) Sleep Aids Medication Market?

    Major companies operating in the over-the-counter (OTC) sleep aids medication market are Pfizer Inc., Johnson & Johnson, Boiron Société Anonyme, Hims & Hers Health Incorporated, Swanson Health Products Incorporated, Thorne Research Incorporated, Life Extension Foundation Buyers Club Incorporated, Gaia Herbs Incorporated, Herb Pharm LLC, Kirkman Group Incorporated, Bluebonnet Nutrition Corporation, Carlson Laboratories Incorporated, Botanic Choice, Oregon’s Wild Harvest LLC, Sundown Naturals, Micro Ingredients Incorporated, Source Naturals Incorporated, Nature Made, Now Health Group Incorporated, Sleepinox LLC

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-sleep-aids-medication-global-market-report

    Which Region Offers The Most Growth Potential For The Over-The-Counter (OTC) Sleep Aids Medication Market Through 2029?

    North America was the largest region in the over-the-counter (OTC) sleep aids medication market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over-the-counter (OTC) sleep aids medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24644&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Future Demand and Leading Companies Shaping the Over-The-Counter (OTC) Products-Eye Care Market to 2029

    Future Demand and Leading Companies Shaping the Over-The-Counter (OTC) Products-Eye Care Market to 2029

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Forecasted Growth Rate and Market Size of the Over-The-Counter (OTC) Products-Eye Care Market?

    The market size for over-the-counter (OTC) eye care products has experienced robust growth in recent years. Its valuation is anticipated to escalate from $31.17 billion in 2024 to $34.08 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. Factors contributing to growth trends observed in the historical period include a rising incidence of digital eye strain, global increase in the elderly population, heightened awareness regarding eye health and hygiene, and an uptick in self-medication habits. Additionally, the easy accessibility of OTC products in both physical retail outlets and online platforms has also fostered growth.

    Forecasts indicate substantial growth in the over-the-counter (otc) eye care product market in the coming years. An expected surge to $48.08 billion in 2029, with a compound annual growth rate (CAGR) of 9.0%, reflects promising prospects. The projected expansion during the forecast period is due to factors like increased urban pollution and allergens, rising occurrences of lifestyle-linked eye disorders, growth in preventative eye care adoption, product innovation and marketing from dominant players, and heightened demand from thriving economies. Noteworthy trends occurring in the forecast period include the progression in preservative-free formulations, merging of digital health utilities with eye care items, packaging advancements powered by technology, evolution in nanotechnology-driven eye care solutions, and the progression in artificial tear and lubricant formulations.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=24643&type=smp

    Which Factor Is Shaping The Future Of The Over-The-Counter (OTC) Products-Eye Care Market?

    The increase in time spent on digital screens is predicted to contribute to the expansion of the over-the-counter (OTC) eye care product market in the future. The duration spent on screens, whether it be computers, smartphones, or tablets, has surged due to the necessity of remote work and online communications, leading to prolonged daily use of screens. OTC eye care items provide relief from the side effects of extended digital screen exposure by reducing dryness, mitigating irritation, and maintaining hydration in the eyes. For example, the Centers for Disease Control and Prevention, a governmental agency in the US, revealed in October 2024 that from July 2021 to December 2023, more than half of all 12-17 year olds (50.4%) spent an average of 4 or more hours on screens daily, whilst 22.8% spent an average of 3 hours, 17.8% spent 2 hours, 6.1% spent 1 hour, and only 3.0% participated less than an hour each day. The rising digital screen exposure therefore significantly impacts the growth of the over-the-counter (OTC) eye care product market.

    What Is The Segment-Wise Breakdown Of The Over-The-Counter (OTC) Products-Eye Care Market?

    The over-the-counter (OTC) products-eye care market covered in this report is segmented –

    1) By Product: Contact Lenses, Intraocular Lenses, Ocular Health Products, Other Products

    2) By Distribution Channel: Hospitals And Clinics, Retail Stores, Online Stores, Other Distribution Channels

    3) By Application: Dry Eye Treatment, Allergy Relief, Infection Prevention And Treatment, Vision Support, Post-Procedure Eye Comfort

    Subsegments:

    1) By Contact Lenses: Soft Contact Lenses, Rigid Gas Permeable (RGP) Lenses, Hybrid Contact Lenses, Daily Disposable Lenses, Extended Wear Lenses, Cosmetic (Colored) Lenses

    2) By Intraocular Lenses: Monofocal Intraocular Lenses, Multifocal Intraocular Lenses, Toric Intraocular Lenses, Accommodative Intraocular Lenses, Phakic Intraocular Lenses

    3) By Ocular Health Products: Artificial Tears And Lubricants, Antihistamine Eye Drops, Redness Relievers, Antibiotic Eye Drops, Eye Wash Solutions, Nutritional Supplements

    4) By Other Products: Eye Patches And Shields, Eye Compresses, Eyelid Cleansers And Wipes, Blue Light Blocking Glasses, Eye Vitamins And Herbal Remedies, Vision Therapy Tools

    Which Trends Are Redefining The Future Landscape Of The Over-The-Counter (OTC) Products-Eye Care Industry?

    Leading corporations in the over-the-counter (OTC) products-eye care market are prioritizing the development of innovative products, like OTC eye drops, aimed at promoting moisture preservation and offering enduring relief from typical eye discomforts. OTC eye drops, over-the-counter solutions, are utilized to mitigate common eye problems like dryness, redness, irritation, and allergies, offering instant relief by moistening the eyes and fostering overall eye comfort. For instance, Glenmark Pharmaceuticals, an American pharmaceutical business, introduced Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), in the US market in August 2024. This eye drop solution is targeted at meeting the growing customer demand for allergy relief eye drops, positioning itself as a competitive rival to Pataday Twice Daily Relief. This product can be found at primary retail outlets and pharmacies throughout the US, thus broadening Glenmark’s consumer healthcare range.

    Which Companies Hold The Largest Market Share In The Over-The-Counter (OTC) Products-Eye Care Sector?

    Major companies operating in the over-the-counter (OTC) products-eye care market are AbbVie, Novartis AG, Alcon, Intas Pharmaceuticals, Macleods Pharmaceuticals, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Bausch + Lomb, Dr. Reddy’s Laboratories, Cipla Ltd., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical, GlenMark Pharmaceuticals Ltd., Ocusoft Inc., Medicom Healthcare, NovaBay Pharmaceuticals Inc., Himalaya Wellness Company, Grevis Pharmaceuticals, TearRestore Inc., Théa Pharma Inc.

    Get The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-products-eye-care-global-market-report

    How Does Regional Performance Compare Across The Over-The-Counter (OTC) Products-Eye Care Industry?

    North America was the largest region in the over-the-counter (OTC) products-eye care market in 2024. The regions covered in the over-the-counter (OTC) products-eye care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=24643&type=smp

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model